Total Payments
$6,168
2024 Payments
$1,116
Companies
41
Transactions
361
Medicare Patients
5,073
Medicare Billing
$920,576
Payment Breakdown by Category
Food & Beverage$6,145 (99.6%)
Education$22.75 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,145 | 358 | 99.6% |
| Education | $22.75 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,018 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $936.41 | 42 | $0 (2024) |
| ABBVIE INC. | $504.17 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $372.26 | 38 | $0 (2024) |
| PFIZER INC. | $362.66 | 27 | $0 (2024) |
| Lilly USA, LLC | $322.22 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $245.78 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $243.92 | 12 | $0 (2024) |
| Allergan Inc. | $231.97 | 15 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $203.79 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,116 | 56 | ABBVIE INC. ($226.08) |
| 2023 | $825.03 | 47 | Lilly USA, LLC ($194.35) |
| 2022 | $249.73 | 15 | ABBVIE INC. ($81.74) |
| 2021 | $124.46 | 7 | Novo Nordisk Inc ($45.24) |
| 2020 | $120.19 | 1 | Amarin Pharma Inc. ($120.19) |
| 2019 | $1,181 | 80 | AstraZeneca Pharmaceuticals LP ($214.28) |
| 2018 | $1,719 | 104 | Novo Nordisk Inc ($377.76) |
| 2017 | $832.61 | 51 | AstraZeneca Pharmaceuticals LP ($324.36) |
All Payment Transactions
361 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Diabetes | ||||||
| 12/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Biological | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardio-renal | ||||||
| 09/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Bone Health | ||||||
| 08/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.63 | General |
| 08/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Neuropsychiatry | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $33.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Cardio-renal | ||||||
| 07/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: DIABETES | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,077 | 3,520 | $509,626 | $247,920 |
| 2022 | 25 | 1,269 | 3,598 | $531,976 | $242,712 |
| 2021 | 28 | 1,161 | 2,403 | $428,770 | $205,323 |
| 2020 | 32 | 1,566 | 2,763 | $494,236 | $224,620 |
Total Patients
5,073
Total Services
12,284
Medicare Billing
$920,576
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 154 | 2,047 | $259,969 | $123,336 | 47.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 190 | 212 | $64,236 | $26,433 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 237 | $32,763 | $17,492 | 53.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 50 | 170 | $24,310 | $13,731 | 56.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 65 | 154 | $26,334 | $13,661 | 51.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 58 | 63 | $12,474 | $8,777 | 70.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 48 | $21,120 | $7,829 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 127 | $12,446 | $7,174 | 57.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 32 | 111 | $11,655 | $6,241 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $8,385 | $5,314 | 63.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 40 | 42 | $7,392 | $3,677 | 49.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 33 | 36 | $5,760 | $3,555 | 61.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 36 | $6,948 | $3,356 | 48.3% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 17 | $2,992 | $1,991 | 66.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 26 | 27 | $5,427 | $1,773 | 32.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 17 | 17 | $1,700 | $1,283 | 75.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 20 | $2,020 | $796.20 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $780.00 | $590.20 | 75.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 18 | $1,386 | $565.92 | 40.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 25 | $825.00 | $220.58 | 26.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 15 | 19 | $209.00 | $60.99 | 29.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 17 | $187.00 | $57.97 | 31.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 14 | $308.00 | $5.30 | 1.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 154 | 1,583 | $201,041 | $85,072 | 42.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 170 | 191 | $57,873 | $27,980 | 48.3% |
About Dr. Gildardo Ceballos, M.D
Dr. Gildardo Ceballos, M.D is a Internal Medicine healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1689956906.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gildardo Ceballos, M.D has received a total of $6,168 in payments from pharmaceutical and medical device companies, with $1,116 received in 2024. These payments were reported across 361 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($6,145).
As a Medicare-enrolled provider, Ceballos has provided services to 5,073 Medicare beneficiaries, totaling 12,284 services with total Medicare billing of $920,576. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Sugar Land, TX
- Active Since 09/13/2011
- Last Updated 03/24/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689956906
Products in Payments
- FARXIGA (Drug) $481.18
- Victoza (Drug) $404.92
- XIFAXAN (Drug) $348.30
- Ozempic (Drug) $306.39
- JARDIANCE (Drug) $267.54
- BYDUREON (Drug) $262.06
- UBRELVY (Drug) $260.96
- MOUNJARO (Drug) $235.53
- LYRICA (Drug) $184.49
- QULIPTA (Drug) $164.25
- Kerendia (Drug) $138.25
- ELIQUIS (Drug) $125.23
- Vascepa (Drug) $120.19
- LINZESS (Drug) $107.03
- Veozah (Drug) $106.06
- VERQUVO (Drug) $88.59
- MYRBETRIQ (Drug) $85.02
- ENTRESTO (Drug) $80.84
- Rybelsus (Drug) $79.75
- TOUJEO (Drug) $78.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sugar Land
Bartley Gill, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $192,377
Internal Medicine $192,377
Zaka Khan
Internal Medicine — Payments: $53,446
Internal Medicine $53,446
Dr. Josier Nisnisan, Md, MD
Internal Medicine — Payments: $32,318
Internal Medicine $32,318
Dr. Ryan Valicek, M.d, M.D
Internal Medicine — Payments: $30,133
Internal Medicine $30,133
Dr. Nerissa D'silva, Md, MD
Internal Medicine — Payments: $27,654
Internal Medicine $27,654
Michael Koo, Md, MD
Internal Medicine — Payments: $26,732
Internal Medicine $26,732